Skip to Main Content

Paper Details

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
BMC Cancer
1
2019
Author NameAffiliation
Matthew P DeekSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Tamara L LotanJohns Hopkins University School of Medicine
Channing J PallerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Channing J PallerThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Mark C MarkowskiSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Michael A CarducciSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Michael A CarducciThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Mario A EisenbergerThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Mario A EisenbergerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Tomasz M BeerOHSU Knight Cancer Institute, Oregon Health & Science University
Danny Y SongSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Danny Y SongSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Danny Y SongThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Theodore L DeWeeseSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Theodore L DeWeeseSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Theodore L DeWeeseThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Stephen GrecoSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Curtiland DevilleSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Neil B DesaiUniversity of Texas Southwestern Medical Center
Elisabeth I HeathKarmanos Cancer Institute, Wayne State University School of Medicine
Daniel E SprattUniversity of Michigan ann arbor
Emmanuel S AntonarakisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Phuoc T TranSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Phuoc T TranSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Phuoc T TranThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
  • 1 - 25

Datasets

Release 1.2